Latest news

Filter by
May 17, 2022 12:30 PM

New funding boosts Garvan breast cancer research

NBCF backs Garvan researchers with $2.99 million in grants to improve treatments and uncover new therapies.

Nov 05, 2021 10:54 AM

NHMRC awards Ideas Grants to 10 Garvan researchers

Garvan researchers will share in $7.1 million in Ideas Grants from the National Health and Medical Research Council.

Sep 22, 2021 08:01 AM

Epigenetic change found in cancers linked to DNA’s 3D instab...

DNA demethylation – an epigenetic change commonly observed in cancers – is linked to changes in DNA’s 3D arrangement and how it replicates itself when cells divide.

May 11, 2021 08:06 AM

New funding to progress breast cancer research

The National Breast Cancer Foundation has awarded five research grants to Garvan researchers.

MEDIA RELEASE: Jan 17, 2020 08:57 AM

Hormone resistance in breast cancer linked to DNA ‘rewiring’...

Garvan researchers have revealed changes to the 3D arrangement of DNA linked to treatment resistance in ER+ breast cancer.

MEDIA RELEASE: Oct 30, 2019 06:00 AM

NSW Premier’s Prize honours epigenetics expert

Professor Susan Clark FAA, has been awarded the 2019 NSW Premier’s Prize for Excellence in Medical Biological Sciences.

Jul 08, 2019 11:12 AM

Genomic ‘map’ reveals not all fat is equal

Garvan and CSIRO researchers have uncovered key differences underlying harmful and non-harmful fat.

Mar 12, 2019 09:21 AM

Cancer DNA’s bad timing

The ‘mistakes’ in cancer DNA may be linked to not only how – but when – DNA is copied when cells divide.

MEDIA RELEASE: Feb 12, 2019 03:00 AM

A new pattern of DNA tags points to a ‘seed’ for cancer

A close-up view of the two meters of DNA inside prostate cancer cells has uncovered new clues about how normal cells turn cancerous.

MEDIA RELEASE: Dec 03, 2018 09:22 AM

Blood test could predict if chemotherapy will work for advan...

World-first trial by Australian researchers

MEDIA RELEASE: May 02, 2018 06:30 AM

Revealed: the ‘city’ of cells supporting prostate tumours

A study led by researchers at the Garvan Institute of Medical Research and Monash University’s Biomedicine Discovery Institute (BDI) has shed light on the cells that surround and support prostate tumours.

MEDIA RELEASE: Feb 08, 2018 12:44 PM

Setting their sights on cancer relapse

An Australian-led team has been shortlisted for Cancer Research UK's Grand Challenge Award: the world's most ambitious cancer research grant.

Nov 16, 2017 03:13 PM

How genes drive prostate cancer: all in the packaging?

Garvan researchers have shown that a unique protein, H2A.Z, which packages DNA in cells, may drive the progression of prostate cancer. When it becomes chemically ‘tagged,’ H2A.Z uncoils and re-organises the DNA in cancer...

Sep 08, 2016 09:29 AM

‘Forgotten molecule’ takes centre stage in cancer gene silen...

Research from Garvan’s Genomics and Epigenetics Division has shed new light on how genes are silenced in cancer. The findings reveal how DNA becomes chemically decorated (methylated) at key sites across the genome in can...

Jun 06, 2016 11:43 AM

A 3D view of the cancer genome

Researchers from Garvan's Genomics and Epigenetics Division have shown, for the first time, how the three-dimensional structural organisation of the genome is altered in cancer cells.

Dec 09, 2015 01:36 PM

Schizophrenia and DNA methylation in the developing brain

An international team of researchers, including Garvan’s Dr Ruth Pidsley, has shed new light on how DNA sequence variation can influence the developing brain.

MEDIA RELEASE: Jul 15, 2015 12:00 AM

How some breast cancers become resistant to hormone therapy

New findings from Garvan have identified how ‘oestrogen receptor positive’ breast cancers become resistant to hormone therapy.

Feb 25, 2015 02:41 PM

Students Receive Awards at 2015 Lorne Genome Conference

Congratulations to Ksenia Skvortsova, Amanda Khoury and Qian Du.

Feb 19, 2015 12:00 AM

Saul Bert Awarded 2014 Garvan Thesis Prize

Congratulations to PhD student Saul Bert.

MEDIA RELEASE: Feb 02, 2015 09:00 PM

Epigenetic signatures that differentiate triple-negative bre...

Australian researchers have identified epigenetic ‘signatures’ that could help clinicians tell the difference between highly aggressive and more benign forms of triple-negative breast cancer.

MEDIA RELEASE: Jul 23, 2013 02:05 PM

New hope for hormone resistant breast cancer

A new finding provides fresh hope for the millions worldwide with oestrogen receptor positive breast cancer. Garvan scientists have shown that a specific change, which occurs when tumours become resistant to anti-oestrog...